Diana Laura is an Ophthalmology physician. OpenAlex indexes 26 publications with 225 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Apellis Pharmaceuticals, Inc.Program year20252 payments
- Regeneron Healthcare Solutions, Inc.Program year20252 payments
- Neurotech Pharmaceuticals, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
86.6%Antineovascularisation agents84.7%Faricimab-svoa100%Part B, office-administered≥43 patientsAminoglycoside Antibacterial0.8%Neomycin-Polymyxin-Dexameth100%Part D≥78 patients+ 4 more classes in this area
Cancer & immunology
12.5%Vascular Endothelial Growth Factor Inhibitor12.5%Aflibercept100%Part B, office-administered≥204 patientsMusculoskeletal
0.5%Cyclooxygenase Inhibitor0.5%Ketorolac Tromethamine100%Part D≥45 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Nocardia Scleritis Progressing to Endophthalmitis in the Setting of Scleral Buckle Extrusion
Ophthalmic surgery, lasers & imaging retina
2023 - Haptic Erosion Following Sutureless Scleral-fixated Intraocular Lens Placement
Ophthalmology Retina
2022 - Acute-onset postoperative endophthalmitis after cataract surgery performed by resident and attending physicians at a university teaching hospital
Journal of Cataract & Refractive Surgery
2022 - Retinal Folds as a Clinical Feature of X-Linked Retinoschisis: A Series of Three Cases
Ophthalmic surgery, lasers & imaging retina
2022
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Robert Weinreb, MD
University of California San Diego
Emily Chew, MD
National Eye Institute
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”